Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Esposti

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Urological Research|January 1, 1982
Prediction of survival and recurrence in bladder carcinomaB Nilsson, B Wahren, P L Esposti, et al.
Cancer|March 15, 1992
The prognostic significance of nuclear DNA content in prostatic carcinomaG Forsslund, P L Esposti, B Nilsson, et al.
The Journal of Urology|December 1, 1978
Clinical experimental randomized study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of prostatic carcinomaF Edsmyr, P L Esposti, B Johansson, et al.
Urological Research|January 1, 1978
Radiation treatment of urinary bladder carcinomaF Edsmyr, P L Esposti, G Giertz, et al.
Acta Radiologica. Oncology|January 1, 1983
Spontaneous cytotoxicity of blood lymphocytes following local radiation therapy for carcinoma of the urinary bladderH Blomgren, F Edsmyr, P L Esposti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trialH Blomgren, F Edsmyr, P L Esposti, et al.
Urology|July 1, 1991
Squamous metaplasia in hormonally treated prostatic cancer. Significance during follow-upD K Das, P O Hedlund, T Lowhagen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trialH Blomgren, I Näslund, P L Esposti, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinomaH Blomgren, P L Esposti, I Näslund, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Treatment of prostatic carcinoma by gonadotropin inhibition with danazol. A preliminary reportD L Freedman, K Carlström, P L Esposti, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Urological Research|January 1, 1982
Prediction of survival and recurrence in bladder carcinomaB Nilsson, B Wahren, P L Esposti, et al.
Cancer|March 15, 1992
The prognostic significance of nuclear DNA content in prostatic carcinomaG Forsslund, P L Esposti, B Nilsson, et al.
The Journal of Urology|December 1, 1978
Clinical experimental randomized study of 2.6-cis-diphenylhexamethylcyclotetrasiloxane and estramustine-17-phosphate in the treatment of prostatic carcinomaF Edsmyr, P L Esposti, B Johansson, et al.
Urological Research|January 1, 1978
Radiation treatment of urinary bladder carcinomaF Edsmyr, P L Esposti, G Giertz, et al.
Acta Radiologica. Oncology|January 1, 1983
Spontaneous cytotoxicity of blood lymphocytes following local radiation therapy for carcinoma of the urinary bladderH Blomgren, F Edsmyr, P L Esposti, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trialH Blomgren, F Edsmyr, P L Esposti, et al.
Urology|July 1, 1991
Squamous metaplasia in hormonally treated prostatic cancer. Significance during follow-upD K Das, P O Hedlund, T Lowhagen, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trialH Blomgren, I Näslund, P L Esposti, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Adjuvant bestatin (Ubenimex) treatment following full-dose local irradiation for bladder carcinomaH Blomgren, P L Esposti, I Näslund, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1980
Treatment of prostatic carcinoma by gonadotropin inhibition with danazol. A preliminary reportD L Freedman, K Carlström, P L Esposti, et al.
Pageof 5